Artiva Biotherapeutics

Artiva Biotherapeutics

Artiva Biotherapeutics

Artiva Biotherapeutics is an oncology company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.
Founded
2019
Raised
$78M
Follow us
Latest funding
$78,000,000
Venture capital (Series A) - 2020
RA Capital Management 5AM Ventures Medivate Partners +3
Team Size
1–10
Employees
$78,000,000 Venture capital (Series A)
Pulse 2.0

Allogeneic Natural Killer Cell Therapy Company Artiva Biotherapeutics Raises $78 Million